TherapeuticsMD (TXMD) Return on Sales (2011 - 2026)

TherapeuticsMD's Return on Sales history runs 16 years deep, the most recent figure standing at 0.0% for Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at TherapeuticsMD, down from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 3.65% in Q2 2022 and bottomed at 0.45% in Q1 2022.
• A 5-year average of 0.14% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2022 — Return on Sales surged 367 bps — and 2023, when it plunged 365 bps.
• TherapeuticsMD's Return on Sales stood at 0.0% in 2022, then soared by 229 bps to 0.01% in 2023, then slumped by 85 bps to 0.0% in 2024, then plunged by 104 bps to 0.0% in 2025, then sank by 41 bps to 0.0% in 2026.
• Business Quant data shows TXMD's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.